Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
Indian Journal of Pathology: Research and Practice

Volume  6, Issue 3(part-1), Jul-Sep 2017, Pages 535-540
 

Original Article

Study of Utility of p63 Immunohistochemical Stain to Differentiate Urothelial Carcinomas of Urinary Bladder from Adenocarcinomas of Prostate

Bhavani Adepu*, Prasuna Chilveri**, Anunayi***

*Assistant Professor, Department of Pathology, Maheshwara Medical College, Patancheru, Telangana, India. **Assistant Professor, Department of Pathology, Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar, Telangana, India. ***Associate Professor, Department of Pathology, Osmania Medical College, Hyderabad, Telangana, India.

Choose an option to locate / access this Article:
90 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.6317.5

Abstract

Introduction: Cancer of the bladder and of prostate are commonmalignancies all over the world. In some cases it is difficult to point to the exact primary due to the anatomical location and morphology of the tumors from these two sites. Various immunohistochemical markers can be used to identify the primary site and p63 is one such marker. Aim of the study: To study the expression of p63 in urothelial carcinoma and prostatic adenocarcinoma so as to differentiate between the two carcinomas. Materials and Methods: In this study, formalin fixed paraffin blocks from 60 cases of urothelial carcinomas of urinary bladder and 20 cases of prostatic adenocarcinomas were examined on light microscopy and tissue sections from all 80 cases were studied for immunohistochemical staining with p63 marker. Observations and Results: The mean age of patients of urothelial carcinoma and of prostate carcinoma was 54.1 and 64.5 years respectively. There were 28 cases (46.6%) of low grade and 32 cases (53.3%) of high grade urothelial carcinomas. The Gleason score for prostatic carcinoma was 56 for 8 patients, 78 for 9 patients and 910 for 3 patients.In 60 urothelial carcinomas 90% of cases showed p63 positivity. All the 20 cases of prostatic adenocarcinomas were negative for p63. Conclusion: p63 is a reliable marker of urothelial differentiation and it can be used in morphologically difficult cases when the differential diagnosis is between poorly differentiated adenocarcinoma of prostate and high grade urothelial carcinoma of urinary bladder.

Keywords: Urothelial Carcinoma of Bladder; Prostatic Carcinoma; p63 Staining.


Corresponding Author : Dr. Bhavani A., Plot no135 & 136, Flat no: 301, Akruthi Sulochana towers, near badminton court, KTR colony roadno: 5, Nijampet, Hyderabad500090, India.